• Jump to main navigation
  • Jump to content
U of U Health
  • Billing & Insurance
  • MyChart
Search
  • Find A U of U Health Doctor
  • All U of U Health Services
  • All U of U Health Locations
  • For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart
  • Search

Mark Deneau, MD, MS, FAAP

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
0 out of 5 Patient Rating

Languages Spoken: English

Dr. Deneau is active in all aspects of pediatric gastroenterology and endoscopy. His main areas of clinical expertise are: inflammatory bowel disease (IBD; ulcerative colitis and Crohn disease), neonates and infants with liver disease and short bowel syndrome, and the inpatient care of very ill and hospitalized patients. Dr. Deneau is a member of the inflammatory bowel disease clinic. He has IBD himself, and has been down the same road as many of his patients, with a first-hand knowledge of what it is like to live with this problem and have surgery. He is not shy about sharing his personal experiences with his patients when helpful. He truly takes this disease to heart, and tries to make the lives of his IBD patients better. Dr. Deneau created and directs a unique neonatal intensive care unit (NICU) gastroenterology clinic. Ill infants in the NICU, who often require months-long hospitalizations for complex bowel and liver diseases, are now seen by only one gastroenterologist for their entire stay in the hospital and after going home. This program helps facilitate better communication, gives families one familiar face who knows their child well, and most importantly, tries to get patients home faster. Dr. Deneau takes a conservative and thoughtful approach to patient care, and tries to avoid invasive procedures and excessive testing when possible. His goal is to make gastrointestinal diseases and symptoms as small a part of his patient's day-to-day lives as possible. Dr. Deneau is active in teaching and training medical students, pediatric residents, and fellows. He has won multiple teaching awards and brings this talent for communication to his patient care. He excels at making sure his patients and families understand their diagnoses, procedures and medications. Dr. Deneau is active in clinical research of liver disease in patients with inflammatory bowel disease, especially primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH). He is active in multiple quality improvement projects throughout the hospital to improve patient safety and lower costs of care for gastrointestinal diseases.

Clinical Locations

Eccles Primary Children’s Outpatient Services Building

801-213-3599

81 N Mario Capecchi Drive
Salt Lake City, UT  84113
Map

Primary Children's Hospital Outpatient Services at Riverton

801-212-3359

3773 West 12600 South
Riverton, UT  84065

Specialties

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease/Crohn's/Ulcerative Colitis
  • Liver Disease
  • Enteral Nutrition

Board Certification and Academic Information

Academic Departments Pediatrics - Associate Professor (Clinical)
Academic Divisions Pediatric Gastroenterology
Board Certification American Board of Pediatrics (Sub: Pediatric Gastroenterology)
American Board of Pediatrics (Pediatrics)

Dr. Deneau is active in all aspects of pediatric gastroenterology and endoscopy. His main areas of clinical expertise are: inflammatory bowel disease (IBD; ulcerative colitis and Crohn disease), neonates and infants with liver disease and short bowel syndrome, and the inpatient care of very ill and hospitalized patients. Dr. Deneau is a member of the inflammatory bowel disease clinic. He has IBD himself, and has been down the same road as many of his patients, with a first-hand knowledge of what it is like to live with this problem and have surgery. He is not shy about sharing his personal experiences with his patients when helpful. He truly takes this disease to heart, and tries to make the lives of his IBD patients better. Dr. Deneau created and directs a unique neonatal intensive care unit (NICU) gastroenterology clinic. Ill infants in the NICU, who often require months-long hospitalizations for complex bowel and liver diseases, are now seen by only one gastroenterologist for their entire stay in the hospital and after going home. This program helps facilitate better communication, gives families one familiar face who knows their child well, and most importantly, tries to get patients home faster. Dr. Deneau takes a conservative and thoughtful approach to patient care, and tries to avoid invasive procedures and excessive testing when possible. His goal is to make gastrointestinal diseases and symptoms as small a part of his patient's day-to-day lives as possible. Dr. Deneau is active in teaching and training medical students, pediatric residents, and fellows. He has won multiple teaching awards and brings this talent for communication to his patient care. He excels at making sure his patients and families understand their diagnoses, procedures and medications. Dr. Deneau is active in clinical research of liver disease in patients with inflammatory bowel disease, especially primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH). He is active in multiple quality improvement projects throughout the hospital to improve patient safety and lower costs of care for gastrointestinal diseases.

Academic Locations

Eccles Primary Children’s Outpatient Services Building

801-213-3599

81 N Mario Capecchi Drive
Division of Pediatric Gastroenterology, Hepatology and Nutrition
Salt Lake City, UT  84113

Board Certification and Academic Information

Academic Departments Pediatrics - Associate Professor (Clinical)
Academic Divisions Pediatric Gastroenterology
Board Certification American Board of Pediatrics (Sub: Pediatric Gastroenterology)
American Board of Pediatrics (Pediatrics)

Education History

Fellowship University of Utah
Pediatric Gastroenterology, Hepatology and Nutrition
Fellow
Graduate Training University of Utah
Clinical Investigation
M.S.
Residency University of Utah
General Pediatrics
Resident
Professional Medical Wayne State University
Medicine
M.D.
Undergraduate Purdue University
Electrical Engineering
B.S.

Selected Publications - Journal Articles

Journal Article

  1. Deneau M, Mack C, Abdou R, Alqoaer K, Amir A, Auth M, Bazerbachi F, Broderick A, Chan A, DiGuglielmo M, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand F, Gupta N, Homan M, Jensen MK, Kim, KM, Kolho K, Konidari A, Koot B, Iorio R, Martinez M, Mohan P, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Vos M, Woynarowski M, Yap J, Miloh T (10/1/2018). Gamma glutamyltransferase reduction leads to favorable long-term outcomes in pediatric primary sclerosing cholangitis. Hepatol Commun, (Nov 2018).
  2. Sandweiss D, Allen L, Deneau M, Harnsberger J, Pasmann A, Smout R, Mundorff M, Dudley N (8/2/2018). Implementing a standardized constipation management pathway to reduce resource utilization. Acad Pediatr.
  3. Soufi N, Bazerbachi F, Deneau M (6/1/2018). Post-transplant disease recurrence in pediatric primary sclerosing cholangitis. Curr Gastroenterol Rep.
  4. Deneau M, Mutyala K, Harnsberger J, Varier R, Sandweiss D, Pohl JF, Maloney C (10/15/17). Reducing Hospital Admissions of Healthy Children with Functional Constipation – A Quality Initiative. BMJ Qual Improv Rep.
  5. Jaramillo C, Valentino P, Deneau M (7/1/2017). Update on Primary Sclerosing Cholangitis and Autoimmune Hepatitis Overlap Syndrome in Childhood. Curr Hepatol Rep, 2017(3).
  6. Deneau M, Bazerbachi F, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J (3/15/2017). The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration. Hepatology, 66(2), 518-527.
  7. Sauberman LJ, Deneau M, Falcone RA, Murray KF, Ali S, Kohli R, Ekong UD, Valentino PL, Grossman AB, Rand EB, Jonas MM, Saeed SA, Kamath BM (12/15/2016). Hepatic Issues and Complications Associated with Inflammatory Bowel Disease. A Clinical Report from the NASPGHAN Inflammatory Bowel Disease and Hepatology Committees. J Pediatr Gastroenterol Nutr, 64(4), 639-652.
  8. Jimenez-Rivera C, Ling SC, Ahmed N, Yap J, Aglipay M, Barrowman N, Graitson S, Critch J, Rashid M, Ng VL, Roberts EA, Brill H, Dowhaniuk JK, Bruce G, Bax K, Deneau M, Guttman OR, Schreiber RA, Martin S, Alvarez F (2015). Incidence and Characteristics of Autoimmune Hepatitis. Pediatrics, 136(5), 1237-1248.
  9. Lascurain L, Jensen MK, Holmen G, Guthery SL, Deneau M (2015). Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis. Inflamm Bowel Dis.
  10. Deneau M, Book LS, Guthery SL, Jensen MK (2014). Outcome after discontinuation of immunosuppression in children with autoimmune hepatitis: a population-based study. J Pediatr, 164(4), 714-719.e2.
  11. Deneau M, Jensen MK, Holmen J, Williams MS, Book LS, Guthery SL (2013). Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history. Hepatology, 58(4), 1392-400.

Abstract

  1. Deneau M, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Bazerbacki F, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J (10/1/2018). Clinical Outcomes of Oral Vancomycin Therapy in Children in the Pediatric PSC Consortium [Abstract]. Hepatology, 68(S1).
  2. Deneau M, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Bazerbacki F, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J (10/1/2018). Variability in Diagnostic and Therapeutic Practices Between Centers in the Pediatric PSC Consortium [Abstract]. Hepatology, 68(S1).
  3. Deneau M, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Bazerbacki F, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J (10/1/2018). MELD and Liver Transplantation in Pediatric Primary Sclerosing Cholangitis, Data From the Pediatric PSC Consortium [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 66(S1).
  4. Johnson E, Deneau M, Ermarth A (10/1/2018). A NOVEL CARE MODEL FOR INTESTINAL FAILURE PATIENTS IN THE NICU: EARLIER DISCHARGE, FEWER READMISSIONS, AND MULTIMILLION DOLLAR COST SAVINGS [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 66(S1).
  5. Jaramillo C, Guthery S, Deneau M (11/1/2017). Inflammatory Bowel Disease in Hispanic Children: A Population-Based Study [Abstract]. Jounral of Pediatric Gastroenterology and Nutrition, 65(S2), S39-S40.
  6. Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Bazerbacki F, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J, Deneau M (11/1/2017). Primary Sclerosing Cholangitis with and without Association Inflammatory Bowel Disease: Data from the Pediatric PSC Consortium [Abstract]. Jounral of Pediatric Gastroenterology and Nutrition, 65(S2), S48-S49.
  7. McClain A, Anderson C, Leukler J, Deneau M (11/1/2017). Early vs. Late Initiation of Parenteral Nutrition in a Pediatric ICU: A Quality Improvement Initiative [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 65(S2), S79-S80.
  8. Deneau M, Mutyala K, Book L, Ermarth A, Guthery S, Harnsberger J, Jaramillo C, Jackson WD, Jensen MK, Kavan M, McClain A, OGorman M, Patel R, Pohl JF, Robson J, Sandweiss D, Sutton T, Varier R, Maloney C (11/1/2017). How We Stopped Admitting Children for Bowel Cleanouts [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 65(S2), S144-S145.
  9. Deneau M, Guthery S (11/1/2017). Cancer is More Common in Children with Inflammatory Bowel Disease Regardless of Immunosuppression Regimen [Abstract]. Jounral of Pediatric Gastroenterology and Nutrition, 65(S2), S232-S233.
  10. Deneau M, Bazerbachi F, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J (11/1/2017). Validating the Mayo Model of Primary Sclerosing Cholangitis Outcomes in Children: Data from the Pediatric PSC Consortium [Abstract]. Jounral of Pediatric Gastroenterology and Nutrition, 65(S2), S162.
  11. Deneau M, Bazerbachi F, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J (11/1/2017). Improvement in GGT Predicts Event-Free Survival in Primary Sclerosing Cholangitis Regardless of Ursodeoxycholic Acid Treatment: Data from the Pediatric PSC Consortium [Abstract]. Jounral of Pediatric Gastroenterology and Nutrition, 65(S2), S105-106.
  12. Deneau M, Bazerbachi F, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J (10/1/2017). Validating the Mayo Model of Primary Sclerosing Cholangitis Outcomes in Children: Data from the Pediatric PSC Consortium [Abstract]. Hepatology, 66(S1), 649-650A.
  13. Deneau M, Bazerbachi F, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J (10/1/2017). Improvement in GGT Predicts Event-Free Survival in Primary Sclerosing Cholangitis Regardless of Treatment with Ursodeoxycholic Acid: Data from the Pediatric PSC Consortium [Abstract]. Hepatology, 66(S1), 58A.
  14. Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Bazerbacki F, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J, Deneau M (4/1/2017). A comparison of primary sclerosing cholangitis with and without associated inflammatory bowel disease: data from the pediatric PSC consortium [Abstract]. Journal of Pediatric Gastroenterology and Nutrition (JPGN), 64(Supplement 1), S576.
  15. Bazerbachi F, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J, Deneau M (4/1/2017). Recurrence of primary sclerosing cholangitis after liver transplantation in children: data from the Pediatric PSC Consortium [Abstract]. Gastroenterology, 152(5 (supplement 1)), S1062-1064.
  16. Bazerbachi F, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J, Deneau M (4/1/2017). Recurrence of primary sclerosing cholangitis after liver transplantation in children: data from the Pediatric PSC Consortium [Abstract]. Journal of Hepatology, 66(Supplement 1), S76.
  17. Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Bazerbacki F, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J, Deneau M (4/1/2017). A comparison of primary sclerosing cholangitis with and without associated inflammatory bowel disease: data from the pediatric PSC consortium [Abstract]. Gastroenterology, 152(5 (Supplement 1)), S1057.
  18. Deneau M, El-Matary W, Varier R, Auth M, Konidari A, Miloh T, Shteyer E, Ledder O, Abdou R, Vitola B, Homan M, Papadopoulou A, Furuya K, Kim K, Woynarowski M, Gottrand M, Gottrand F, Broderick A, Valentino P, Martinez M, Ricciuto A, Kamath B, Venkat V, Gupta N, Iorio R, Bazerbachi F, El-Youssef M, Kolho K, Amin M, Doan S, Jensen MK (October 2016). Ursodeoxycholic acid treatment does not improve liver outcomes in pediatric PSC: a multicenter, international collaboration [Abstract]. Hepatology, 63(1), 349A.
  19. Deneau M, El-Matary W, Varier R, Auth M, Konidari A, Miloh T, Shteyer E, Ledder O, Abdou R, Vitola B, Homan M, Papadopoulou A, Furuya K, Kim K, Woynarowski M, Gottrand M, Gottrand F, Broderick A, Valentino P, Martinez M, Ricciuto A, Kamath B, Venkat V, Gupta N, Iorio R, Bazerbachi F, El-Youssef M, Kolho K, Amin M, Doan S, Jensen MK (October 2016). The Natural History of Primary Sclerosing Cholangitis in 500 Children: A multicenter, international collaboration [Abstract]. Hepatology, 63(1), 72A.
  20. Ricciuto A, Kamath B, El-Matary W, Varier R, Auth M, Konidari A, Miloh T, Shteyer E, Ledder O, Abdou R, Vitola B, Homan M, Papadopoulou A, Furuya K, Kim K, Woynarowski M, Gottrand M, Gottrand F, Broderick A, Valentino P, Martinez M, Venkat V, Gupta N, Iorio R, Bazerbachi F, El-Youssef M, Kolho K, Amin M, Doan S, Jensen MK, Deneau M (October 2016). Primary sclerosing cholangitis and autoimmune sclerosing cholangitis are associated with similar outcomes: data from the pediatric PSC consortium [Abstract]. Hepatology, 63(1), 352A.
  21. Deneau M, El-Matary W, Varier R, Auth M, Konidari A, Miloh T, Shteyer E, Ledder O, Abdou R, Vitola B, Homan M, Papadopoulou A, Furuya K, Kim K, Woynarowski M, Gottrand M, Gottrand F, Broderick A, Valentino P, Martinez M, Ricciuto A, Kamath B, Venkat V, Gupta N, Iorio R, Bazerbachi F, El-Youssef M, Kolho K, Amin M, Doan S, Jensen MK (October 2016). Laboratory predictors of longterm prognosis in primary sclerosing cholangitis: data from the pediatric PSC consortium [Abstract]. Hepatology, 63(1), 350A.
  22. Mutyala R, Jaramillo C, Ermarth A, Weinheimer C, Jackson WD, Coombs S, Deneau M (10/6/2016). Early discharge of intestinal failure patients from the NICU: a pilot quality improvement initiative [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 63(S), S401.
  23. Sylvia Doan, Wael El-Matary, Raghu Varier, Anastasia Konidari, Marcus Auth, M Kyle Jensen, Deneau M (2015). Predictors of poor outcome in pediatric primary sclerosing cholangitis: a multicenter collaboration [Abstract]. Hepatology, 62(S1), 1038A.
  24. Ermarth A, Deneau M (2015). Clinical characteristics of very early onset inflammatory bowel disease: a population-based cohort [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 61(S2), S22.
  25. Lascurain L, Deneau M (2015). Inflammatory bowel disease spares the poor but autoimmune hepatitis does not: socioeconomic factors in immune-mediated disease in Utah [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 61(S2), S174.
  26. Sylvia Doan, Wael El-Matary, Raghu Varier, Anastasia Konidari, Marcus Auth, M Kyle Jensen, Deneau M (2015). Predictors of poor outcome in pediatric primary sclerosing cholangitis: a multicenter collaboration [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 61(S2), 184.
  27. Ramakrishna Mutyala, Deneau M, Linda Book, Robin Kim, Ronald Day, M Kyle Jensen (2015). Frequency and Impact of Severe Hepatopulmonary Syndrome on Liver Transplantation in Children [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 61(S2), S187.
  28. Mhanni A, Rockman-Greenberg C, Deneau M, Hartley J (10/1/2014). Mesenteric lymphadenopathy and protein-losing enteropathy in Gaucher disease type 3 despite combined enzyme replacement and substrate reduction therapy [Abstract]. Clinical Biochemistry, 47(15), 139.
  29. Lascurain L, Deneau M, Guthery SL, Jensen MK (2013). Inflammatory bowel disease activity and distribution in children with and without primary sclerosing cholangitis [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 57(Suppl 1).
  30. Deneau M, Book L, Guthery SL, Jensen MK (2013). Sustained immunosuppression-free remission in pediatric autoimmune hepatitis: a population-based study [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 57(Suppl 1).
  31. Deneau M, Book L, Guthery SL, Jensen MK (2013). Sustained immunosuppression-free remission in pediatric autoimmune hepatitis: a population-based study [Abstract]. Hepatology, 58(S1).
  32. Deneau M, Jensen MK, Holmen J, Williams MS, Bleyl S, Guthery S (2012). Pediatric Primary Sclerosing Cholangitis and Inflammatory Bowel Disease in Utah: A Population-Based Study [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 55(Suppl 1).

Global Impact

Selected Provider Publications

Journal Article

  1. Deneau M, Mack C, Abdou R, Alqoaer K, Amir A, Auth M, Bazerbachi F, Broderick A, Chan A, DiGuglielmo M, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand F, Gupta N, Homan M, Jensen MK, Kim, KM, Kolho K, Konidari A, Koot B, Iorio R, Martinez M, Mohan P, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Vos M, Woynarowski M, Yap J, Miloh T (10/1/2018). Gamma glutamyltransferase reduction leads to favorable long-term outcomes in pediatric primary sclerosing cholangitis. Hepatol Commun, (Nov 2018).
    Global Impact: Canada, France, Greece, Ireland, Italy, Japan, Korea, Poland, Slovenia, United Kingdom.

  2. Deneau M, Bazerbachi F, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J (3/15/2017). The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration. Hepatology, 66(2), 518-527.
    Global Impact: Canada, Czech Republic, Finland, France, Greece, Israel, Italy, Japan, Netherlands, Poland, Saudi Arabia, Slovenia, United Kingdom.

  3. Jimenez-Rivera C, Ling SC, Ahmed N, Yap J, Aglipay M, Barrowman N, Graitson S, Critch J, Rashid M, Ng VL, Roberts EA, Brill H, Dowhaniuk JK, Bruce G, Bax K, Deneau M, Guttman OR, Schreiber RA, Martin S, Alvarez F (2015). Incidence and Characteristics of Autoimmune Hepatitis. Pediatrics, 136(5), 1237-1248.
    Global Impact: Canada.

Abstract

  1. Deneau M, Bazerbachi F, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J (10/1/2017). Improvement in GGT Predicts Event-Free Survival in Primary Sclerosing Cholangitis Regardless of Treatment with Ursodeoxycholic Acid: Data from the Pediatric PSC Consortium [Abstract]. Hepatology, 66(S1), 58A.
    Global Impact: Canada, Czech Republic, Finland, France, Greece, Ireland, Israel, Italy, Japan, Korea, Netherlands, Poland, Saudi Arabia, Slovenia, United Kingdom.

  2. Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Bazerbacki F, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J, Deneau M (4/1/2017). A comparison of primary sclerosing cholangitis with and without associated inflammatory bowel disease: data from the pediatric PSC consortium [Abstract]. Journal of Pediatric Gastroenterology and Nutrition (JPGN), 64(Supplement 1), S576.
    Global Impact: Canada, Finland, France, Greece, Ireland, Israel, Italy, Japan, Korea, Netherlands, Poland, Saudi Arabia, Slovenia, United Kingdom.

  3. Bazerbachi F, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J, Deneau M (4/1/2017). Recurrence of primary sclerosing cholangitis after liver transplantation in children: data from the Pediatric PSC Consortium [Abstract]. Journal of Hepatology, 66(Supplement 1), S76.
    Global Impact: Finland, France, Greece, Ireland, Italy, Japan, Korea, Netherlands, Slovenia, United Kingdom.

  4. Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Bazerbacki F, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J, Deneau M (4/1/2017). A comparison of primary sclerosing cholangitis with and without associated inflammatory bowel disease: data from the pediatric PSC consortium [Abstract]. Gastroenterology, 152(5 (Supplement 1)), S1057.
    Global Impact: Canada, Czech Republic, Europe, Japan, Netherlands.

  5. Deneau M, El-Matary W, Varier R, Auth M, Konidari A, Miloh T, Shteyer E, Ledder O, Abdou R, Vitola B, Homan M, Papadopoulou A, Furuya K, Kim K, Woynarowski M, Gottrand M, Gottrand F, Broderick A, Valentino P, Martinez M, Ricciuto A, Kamath B, Venkat V, Gupta N, Iorio R, Bazerbachi F, El-Youssef M, Kolho K, Amin M, Doan S, Jensen MK (October 2016). Ursodeoxycholic acid treatment does not improve liver outcomes in pediatric PSC: a multicenter, international collaboration [Abstract]. Hepatology, 63(1), 349A.
    Global Impact: Canada.

  6. Deneau M, El-Matary W, Varier R, Auth M, Konidari A, Miloh T, Shteyer E, Ledder O, Abdou R, Vitola B, Homan M, Papadopoulou A, Furuya K, Kim K, Woynarowski M, Gottrand M, Gottrand F, Broderick A, Valentino P, Martinez M, Ricciuto A, Kamath B, Venkat V, Gupta N, Iorio R, Bazerbachi F, El-Youssef M, Kolho K, Amin M, Doan S, Jensen MK (October 2016). The Natural History of Primary Sclerosing Cholangitis in 500 Children: A multicenter, international collaboration [Abstract]. Hepatology, 63(1), 72A.
    Global Impact: Canada.

  7. Ricciuto A, Kamath B, El-Matary W, Varier R, Auth M, Konidari A, Miloh T, Shteyer E, Ledder O, Abdou R, Vitola B, Homan M, Papadopoulou A, Furuya K, Kim K, Woynarowski M, Gottrand M, Gottrand F, Broderick A, Valentino P, Martinez M, Venkat V, Gupta N, Iorio R, Bazerbachi F, El-Youssef M, Kolho K, Amin M, Doan S, Jensen MK, Deneau M (October 2016). Primary sclerosing cholangitis and autoimmune sclerosing cholangitis are associated with similar outcomes: data from the pediatric PSC consortium [Abstract]. Hepatology, 63(1), 352A.
    Global Impact: Canada.

  8. Deneau M, El-Matary W, Varier R, Auth M, Konidari A, Miloh T, Shteyer E, Ledder O, Abdou R, Vitola B, Homan M, Papadopoulou A, Furuya K, Kim K, Woynarowski M, Gottrand M, Gottrand F, Broderick A, Valentino P, Martinez M, Ricciuto A, Kamath B, Venkat V, Gupta N, Iorio R, Bazerbachi F, El-Youssef M, Kolho K, Amin M, Doan S, Jensen MK (October 2016). Laboratory predictors of longterm prognosis in primary sclerosing cholangitis: data from the pediatric PSC consortium [Abstract]. Hepatology, 63(1), 350A.
    Global Impact: Canada.

  9. Sylvia Doan, Wael El-Matary, Raghu Varier, Anastasia Konidari, Marcus Auth, M Kyle Jensen, Deneau M (2015). Predictors of poor outcome in pediatric primary sclerosing cholangitis: a multicenter collaboration [Abstract]. Hepatology, 62(S1), 1038A.
    Global Impact: Canada.

  10. Sylvia Doan, Wael El-Matary, Raghu Varier, Anastasia Konidari, Marcus Auth, M Kyle Jensen, Deneau M (2015). Predictors of poor outcome in pediatric primary sclerosing cholangitis: a multicenter collaboration [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 61(S2), 184.
    Global Impact: Canada.

Awards & Honors

Young Investigator Research Award - European Association of the Study of the Liver (EASL) annual meeting France
PSC Partners Seeking A Cure award for outstanding primary sclerosing cholangitis research - American Association for the Study of Liver Diseases Foundation 2017 Canada

Grand Rounds

The Use and Misuse of Proton Pump Inhibitors. The Manitoba Institute of Child Health, John Buhler Research Centre, Winnipeg, Manitoba Canada

Presentations

Natural history of pediatric primary sclerosing cholangitis. Trial Designs and Endpoints for Clinical Trial in Adults and Children with Primary Sclerosing Cholangitis. Joint workshop of the American Association for the Study of Liver Diseases (AASLD) and the U.S. Food and Drug Administration (FDA). March 3, 2016. Silver Spring, Maryland. Canada

Site Links

  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • The Imagine Perfect Care Program

Helpful Links

  • Referring Providers
  • Find an Interpreter
  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

801-581-2121

  • Facebook
  • Twitter
  • Youtube

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2019 University of Utah Health